睡眠起始潜伏期
睡眠卫生
失眠症
活动记录
医学
失眠的认知行为疗法
匹兹堡睡眠质量指数
随机对照试验
物理疗法
睡眠开始
多导睡眠图
注意
置信区间
认知行为疗法
睡眠质量
临床心理学
内科学
精神科
呼吸暂停
作者
Francesca Perini,K.C. Wong,Jia Lin,Zuriel Hassirim,Ju Lynn Ong,June C. Lo,Jason C. Ong,Kinjal Doshi,Julian Lim
标识
DOI:10.1017/s0033291721002476
摘要
Abstract Objective Poor sleep is a modifiable risk factor for multiple disorders. Frontline treatments (e.g. cognitive-behavioral therapy for insomnia) have limitations, prompting a search for alternative approaches. Here, we compare manualized Mindfulness-Based Therapy for Insomnia (MBTI) with a Sleep Hygiene, Education, and Exercise Program (SHEEP) in improving subjective and objective sleep outcomes in older adults. Methods We conducted a single-site, parallel-arm trial, with blinded assessments collected at baseline, post-intervention and 6-months follow-up. We randomized 127 participants aged 50–80, with a Pittsburgh Sleep Quality Index (PSQI) score ⩾5, to either MBTI ( n = 65) or SHEEP ( n = 62), both 2 hr weekly group sessions lasting 8 weeks. Primary outcomes included PSQI and Insomnia Severity Index, and actigraphy- and polysomnography-measured sleep onset latency (SOL) and wake after sleep onset (WASO). Results Intention-to-treat analysis showed reductions in insomnia severity in both groups [MBTI: Cohen's effect size d = −1.27, 95% confidence interval (CI) −1.61 to −0.89; SHEEP: d = −0.69, 95% CI −0.96 to −0.43], with significantly greater improvement in MBTI. Sleep quality improved equivalently in both groups (MBTI: d = −1.19; SHEEP: d = −1.02). No significant interaction effects were observed in objective sleep measures. However, only MBTI had reduced WASO actigraphy (MBTI: d = −0.30; SHEEP: d = 0.02), SOL actigraphy (MBTI: d = −0.25; SHEEP: d = −0.09), and WASO PSG (MBTI: d = −0.26; SHEEP ( d = −0.18). There was no change in SOL PSG . No participants withdrew because of adverse effects. Conclusions MBTI is effective at improving subjective and objective sleep quality in older adults, and could be a valid alternative for persons who have failed or do not have access to standard frontline therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI